Active

SU.RE Investments II

Switched

BE1010475229

Rechtspersoon Naamloze vennootschap 1 establishment

Active for

1 year, 10 months

Registered office

Waterlelielaan 1

9032 Gent

België

Names & denominations

SU.RE Investments II

Official name

NL

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Naamloze vennootschap

Legal situation

Normale toestand

Start date

18 June 2024

Contact

Not specified

Peppol

Active
0208:1010475229

Active since 13 Mar 2026

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

70200 Main activity

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

70220 Main activity

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Waterlelielaan 1

9032 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of SU.RE Investments II?
The enterprise number of SU.RE Investments II is BE1010475229.
What is the address of SU.RE Investments II?
The registered office of SU.RE Investments II is located at Waterlelielaan 1, 9032 Gent.
When was SU.RE Investments II founded?
SU.RE Investments II was founded on 18 June 2024.
What is the main activity of SU.RE Investments II?
The main activity of SU.RE Investments II is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does SU.RE Investments II have a website?
No website is currently known for SU.RE Investments II.